Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.08
LHCG's Cash to Debt is ranked higher than
60% of the 299 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. LHCG: 0.08 )
LHCG' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.08

Equity to Asset 0.63
LHCG's Equity to Asset is ranked higher than
89% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. LHCG: 0.63 )
LHCG' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.82
Current: 0.63

0.34
0.82
Interest Coverage 23.44
LHCG's Interest Coverage is ranked higher than
85% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 4.80 vs. LHCG: 23.44 )
LHCG' s 10-Year Interest Coverage Range
Min: 7.98   Max: 713.45
Current: 23.44

7.98
713.45
F-Score: 4
Z-Score: 4.56
M-Score: -2.82
WACC vs ROIC
9.68%
8.46%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.32
LHCG's Operating margin (%) is ranked higher than
70% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 9.26 vs. LHCG: 6.32 )
LHCG' s 10-Year Operating margin (%) Range
Min: -1.01   Max: 19.53
Current: 6.32

-1.01
19.53
Net-margin (%) 3.01
LHCG's Net-margin (%) is ranked higher than
71% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 4.62 vs. LHCG: 3.01 )
LHCG' s 10-Year Net-margin (%) Range
Min: -2.09   Max: 10.95
Current: 3.01

-2.09
10.95
ROE (%) 7.12
LHCG's ROE (%) is ranked higher than
71% of the 287 Companies
in the Global Medical Care industry.

( Industry Median: 7.86 vs. LHCG: 7.12 )
LHCG' s 10-Year ROE (%) Range
Min: -4.93   Max: 178.18
Current: 7.12

-4.93
178.18
ROA (%) 4.63
LHCG's ROA (%) is ranked higher than
78% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 3.18 vs. LHCG: 4.63 )
LHCG' s 10-Year ROA (%) Range
Min: -3.51   Max: 24.69
Current: 4.63

-3.51
24.69
ROC (Joel Greenblatt) (%) 48.03
LHCG's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 13.15 vs. LHCG: 48.03 )
LHCG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -6.69   Max: 158.29
Current: 48.03

-6.69
158.29
Revenue Growth (3Y)(%) 3.50
LHCG's Revenue Growth (3Y)(%) is ranked higher than
66% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. LHCG: 3.50 )
LHCG' s 10-Year Revenue Growth (3Y)(%) Range
Min: 3.5   Max: 60.8
Current: 3.5

3.5
60.8
EBITDA Growth (3Y)(%) -17.20
LHCG's EBITDA Growth (3Y)(%) is ranked higher than
57% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 6.40 vs. LHCG: -17.20 )
LHCG' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -64.8   Max: 79.5
Current: -17.2

-64.8
79.5
EPS Growth (3Y)(%) -21.40
LHCG's EPS Growth (3Y)(%) is ranked higher than
60% of the 181 Companies
in the Global Medical Care industry.

( Industry Median: 9.50 vs. LHCG: -21.40 )
LHCG' s 10-Year EPS Growth (3Y)(%) Range
Min: -21.4   Max: 116.3
Current: -21.4

-21.4
116.3
» LHCG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

LHCG Guru Trades in Q1 2014

Jim Simons 63,110 sh (+538.25%)
Joel Greenblatt 19,097 sh (-76.51%)
» More
Q2 2014

LHCG Guru Trades in Q2 2014

Jim Simons 80,813 sh (+28.05%)
Joel Greenblatt Sold Out
» More
Q3 2014

LHCG Guru Trades in Q3 2014

Jim Simons 67,200 sh (-16.85%)
» More
Q4 2014

LHCG Guru Trades in Q4 2014

Jim Simons 112,400 sh (+67.26%)
» More
» Details

Insider Trades

Latest Guru Trades with LHCG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-06-30 Sold Out 0.01%$19.9 - $22.3 $ 34.465%0
Joel Greenblatt 2014-03-31 Reduce -76.51%0.04%$21.8 - $24.59 $ 34.448%19097
Joel Greenblatt 2013-09-30 Add 38.92%0.02%$19.3 - $26.49 $ 34.450%84045
Joel Greenblatt 2013-06-30 Add 70.55%0.02%$19.58 - $23.5 $ 34.456%60501
Joel Greenblatt 2013-03-31 New Buy0.04%$20.08 - $22.67 $ 34.462%35475
Richard Snow 2013-03-31 Sold Out 0.04%$20.08 - $22.67 $ 34.462%0
Michael Price 2012-12-31 Sold Out 0.2%$16.33 - $22.12 $ 34.484%0
Richard Snow 2012-12-31 Reduce -21.71%0.01%$16.33 - $22.12 $ 34.484%32225
Michael Price 2012-06-30 Add 281.58%0.13%$16.29 - $18.83 $ 34.497%72500
Richard Snow 2012-06-30 Add 27.35%0.01%$16.29 - $18.83 $ 34.497%46260
Joel Greenblatt 2012-03-31 Sold Out 0.09%$12.57 - $19.71 $ 34.4122%0
Michael Price 2012-03-31 New Buy0.05%$12.57 - $19.71 $ 34.4122%19000
Richard Snow 2011-12-31 Add 90.23%0.01%$12.35 - $18.84 $ 34.4132%39320
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 27.70
LHCG's P/E(ttm) is ranked higher than
82% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 43.30 vs. LHCG: 27.70 )
LHCG' s 10-Year P/E(ttm) Range
Min: 6.45   Max: 33.22
Current: 27.7

6.45
33.22
Forward P/E 18.38
LHCG's Forward P/E is ranked higher than
85% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 26.67 vs. LHCG: 18.38 )
N/A
PE(NRI) 27.70
LHCG's PE(NRI) is ranked higher than
82% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 40.70 vs. LHCG: 27.70 )
LHCG' s 10-Year PE(NRI) Range
Min: 6.38   Max: 28.79
Current: 27.7

6.38
28.79
P/B 2.00
LHCG's P/B is ranked higher than
86% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 3.14 vs. LHCG: 2.00 )
LHCG' s 10-Year P/B Range
Min: 0.88   Max: 4.66
Current: 2

0.88
4.66
P/S 0.80
LHCG's P/S is ranked higher than
83% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 1.73 vs. LHCG: 0.80 )
LHCG' s 10-Year P/S Range
Min: 0.35   Max: 2.36
Current: 0.8

0.35
2.36
PFCF 13.00
LHCG's PFCF is ranked higher than
93% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 47.64 vs. LHCG: 13.00 )
LHCG' s 10-Year PFCF Range
Min: 3.89   Max: 112.88
Current: 13

3.89
112.88
POCF 11.20
LHCG's POCF is ranked higher than
85% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 16.94 vs. LHCG: 11.20 )
LHCG' s 10-Year POCF Range
Min: 3.67   Max: 150.5
Current: 11.2

3.67
150.5
EV-to-EBIT 13.51
LHCG's EV-to-EBIT is ranked higher than
85% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 23.61 vs. LHCG: 13.51 )
LHCG' s 10-Year EV-to-EBIT Range
Min: -59.5   Max: 162.4
Current: 13.51

-59.5
162.4
Shiller P/E 20.40
LHCG's Shiller P/E is ranked higher than
94% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 207.68 vs. LHCG: 20.40 )
LHCG' s 10-Year Shiller P/E Range
Min: 7.72   Max: 20.4
Current: 20.4

7.72
20.4
Current Ratio 1.96
LHCG's Current Ratio is ranked higher than
88% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. LHCG: 1.96 )
LHCG' s 10-Year Current Ratio Range
Min: 1.65   Max: 4.45
Current: 1.96

1.65
4.45
Quick Ratio 1.96
LHCG's Quick Ratio is ranked higher than
90% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. LHCG: 1.96 )
LHCG' s 10-Year Quick Ratio Range
Min: 1.65   Max: 4.45
Current: 1.96

1.65
4.45
Days Sales Outstanding 51.55
LHCG's Days Sales Outstanding is ranked higher than
74% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 52.71 vs. LHCG: 51.55 )
LHCG' s 10-Year Days Sales Outstanding Range
Min: 46.27   Max: 85.77
Current: 51.55

46.27
85.77

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.90
LHCG's Price/DCF (Projected) is ranked higher than
95% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 3.93 vs. LHCG: 0.90 )
LHCG' s 10-Year Price/DCF (Projected) Range
Min: 0.34   Max: 0.77
Current: 0.9

0.34
0.77
Price/Median PS Value 1.00
LHCG's Price/Median PS Value is ranked higher than
89% of the 329 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. LHCG: 1.00 )
LHCG' s 10-Year Price/Median PS Value Range
Min: 0.42   Max: 2.68
Current: 1

0.42
2.68
Earnings Yield (Greenblatt) 7.30
LHCG's Earnings Yield (Greenblatt) is ranked higher than
84% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. LHCG: 7.30 )
LHCG' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.6   Max: 25.8
Current: 7.3

0.6
25.8
Forward Rate of Return (Yacktman) -18.79
LHCG's Forward Rate of Return (Yacktman) is ranked higher than
54% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 9.87 vs. LHCG: -18.79 )
LHCG' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -14   Max: 42.7
Current: -18.79

-14
42.7

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:LH6.Germany,
LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. Through its wholly- and majority-owned subsidiaries, equity joint ventures and controlled affiliates, the company operated in Alabama, Arkansas, California, Florida, Georgia, Idaho, Illinois, Kentucky, Louisiana, Maryland, Minnesota, Mississippi, Missouri, Nevada, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, West Virginia and Wisconsin. The Company operates in two segments: home-based services and facility-based services. As of December 31, 2013, they owned and/or operated 300 home-based service locations, with 255 home nursing agency locations, 34 hospices, three specialty agencies and five private duty agencies, and they managed the operations of three home nursing agencies in which they do not have an ownership interest. As of December 31, 2013, its facility-based services included six LTACHs with nine locations, a pharmacy, and a family health center. Its home nursing locations offer a wide range of services, including skilled nursing, medically-oriented social services and physical, occupational and speech therapy. The nurses, home health aides and therapists in its home nursing agencies work closely with patients and their families to design and implement individualized treatments in accordance with a physician-prescribed plan of care. The Companys hospices provide end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors and volunteers. Of its 300 home-based services locations, 162 are wholly-owned by the company, 128 are majority-owned or controlled by the company through joint ventures, seven are operated through license lease arrangements, and the company manages the operations of three home nursing agencies in which they have no ownership interest. The Companys LTACH locations provide services primarily to patients with complex medical conditions who have transitioned out of a hospital intensive care unit but whose conditions remain too severe for treatment in a non-acute setting. The Company owns and operates six LTACHs with nine locations, of which all but one are located within host hospitals. The Company also own and operate a pharmacy and a family health center. Of these 11 facility-based services locations, six are wholly-owned by the company and five are majority-owned or controlled by the company through joint ventures. The Company is subject to both federal and state income tax for jurisdictions within which it operates.
» More Articles for LHCG

Headlines

Articles On GuruFocus.com
“Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 05 2012 
posible buy Aug 24 2011 
DCF Jul 24 2011 
LHC Group Reports Operating Results (10-K) Mar 10 2011 
LHC Group Reports Operating Results (10-Q) Nov 03 2010 
LHC Group Reports Operating Results (10-Q) Aug 06 2010 
LHC Group (LHCG) CFO Peter J. Roman sells 1,200 Shares May 27 2010 
LHC Group (LHCG) CEO and President, 10% Owner Keith G Myers sells 169,800 Shares May 13 2010 
LHC Group (LHCG) CEO and President, 10% Owner Keith G Myers sells 5,200 Shares May 12 2010 
A Simple Metric to Clarify the Balance Sheet Apr 19 2010 

More From Our Partners
Outpatient, Home Healthcare Set to Gain: 3 Picks - Analyst Blog Mar 4 2015 - ZACKS

More From Other Websites
Outpatient, Home Healthcare Set to Gain: 3 Picks - Analyst Blog Mar 04 2015
LHC Group (LHCG) Shares March Higher, Can It Continue? - Tale of the Tape Mar 03 2015
LHC Group announces a home health joint venture in Missouri with Missouri Delta Medical Center Mar 02 2015
LHC Group Announces a Home Health Joint Venture in Missouri With Missouri Delta Medical Center Mar 02 2015
Correction: Earns-LHC Group story Feb 27 2015
Correction: Earns-LHC Group story Feb 27 2015
LHC Group Inc Earnings Call scheduled for 11:00 am ET today Feb 26 2015
LHC misses 4Q profit forecasts Feb 26 2015
LHC misses 4Q profit forecasts Feb 26 2015
LHC beats Street 4Q forecasts Feb 26 2015
LHC beats Street 4Q forecasts Feb 26 2015
LHC Group announces fourth quarter and full-year 2014 results Feb 25 2015
LHC GROUP, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 25 2015
LHC Group Announces Fourth Quarter and Full-Year 2014 Results Feb 25 2015
Q4 2014 LHC Group Inc Earnings Release - After Market Close Feb 25 2015
LHC Group announces fourth quarter and year-end 2014 earnings release and conference call dates Feb 17 2015
LHC Group Announces Fourth Quarter and Year-End 2014 Earnings Release and Conference Call Dates Feb 17 2015
Cardiocom, Medtronic's Patient Monitoring Services Business, Announces Partnerships with Home Health... Feb 02 2015
LHC Group to present at 33rd Annual J.P. Morgan Healthcare Conference Jan 08 2015
LHC Group to Present at 33rd Annual J.P. Morgan Healthcare Conference Jan 08 2015
LHC Group names Dionne E. Viator executive vice president, chief financial officer and treasurer Dec 04 2014
LHC GROUP, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Dec 04 2014
LHC Group Names Dionne E. Viator Executive Vice President, Chief Financial Officer and Treasurer Dec 04 2014
LHC Group to present at Oppenheimer 25th Annual Healthcare Conference Dec 03 2014
LHC Group to Present at Oppenheimer 25th Annual Healthcare Conference Dec 03 2014
LHC GROUP, INC Financials Nov 14 2014
LHC GROUP, INC Files SEC form 10-Q, Quarterly Report Nov 06 2014
LHC Group announces third quarter 2014 results Nov 06 2014
LHC tops Street 3Q forecasts Nov 06 2014
LHC tops Street 3Q forecasts Nov 06 2014
LHC GROUP, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 05 2014
LHC Group announces a home health joint venture in Alabama with Troy Regional Medical Center and... Nov 03 2014
LHC Group announces third quarter 2014 earnings release and conference call dates Oct 23 2014
Industry-leading review rates 124 LHC Group home health locations among nation’s best Oct 21 2014
DaVita's Acquisitions Look Promising, High Debt a Concern Oct 03 2014
Markets Edge Lower; Zumiez Issues Weak Outlook Sep 05 2014
LHC to acquire Life Care Home Health Jul 15 2014
LHC Group names Chris Duhon national Servant Leader of the Year Mar 19 2014
New Orleans hospice agency undergoes name change Mar 14 2014
LHC Group announces fourth quarter and full-year 2013 results Mar 05 2014
LHC Group celebrates 20 years with ribbon cutting ceremony Mar 04 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK